Syndax Pharmaceuticals Inc (SNDX) › Net IncomeSyndax Pharmaceuticals Inc (SNDX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$19.83M2015: -$24.12M2016: -$44.47M2017: -$60.80M2018: -$73.96M2019: -$56.05M2020: -$73.16M2021: $24.93M2022: -$149.34M2023: -$209.36M2024: -$318.76M2025: -$285.42M-$285.42M2014Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$285.42M+10.5%2024-$318.76M-52.3%2023-$209.36M-40.2%2022-$149.34M-699.1%2021$24.93M+134.1%2020-$73.16M-30.5%2019-$56.05M+24.2%2018-$73.96M-21.6%2017-$60.80M-36.7%2016-$44.47M-84.4%2015-$24.12M-21.6%2014-$19.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share